Central nervous system Cerebrospinal fluid 6-diamidino-2-phenylindole Area postrema syndrome AKRB Ependymal cell Bone Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Immunohistochemical Biobank Endocannabinoid system BBB Neuromyelitis optica spectrum disorder T follicular helper cells T follicular regulatory cells B cells rituximab Rituximab Treatment response Autoimmune encephalitis COVID-19 Demyelination Blood-brain barrier Optic neuritis Adverse events Animal model IHC Cilia Enzyme-linked immunosorbent assays Estradiol Aquaporin-4 Aquaporin-4-IgG AQP4-IgG Blood brain barrier 6-diamidino-2-phenylindole IQR Pregnancy CSF DAPI CNS Breastfeeding NMOSD Drosophila Disease modifying treatments BSA-supplemented Kreps Ringer buffer Biomarkers Neuromyelitis optica Hippocampus Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation CD14 Clinically isolated syndrome CIS B cells Encephalitis BSA-supplemented Kreps Ringer buffer Enzyme-linked immunosorbent assays DAPI CRMP5 CP Neuroscience Multiple sclerosis Myelitis Interquartile range ERRα Immunohistochemical AKRB Bright T follicular helper cells IBMs Relapses Database Cannabinoid receptor type 2 Blood brain barrier IBMs Neuroinflammation IQR Cancer Immune checkpoint inhibitors Adult neurogenesis Glutamate Cancer immunotherapy Antivascular endothelial growth factor Neuromyelitis optica spectrum disorder Neuromyelitis optica spectrum disorders Collapsing response mediator protein Reproductive assistance GABA Circadian clock Registry Glia Prognosis Interquartile range VEGF Anti-GFAP encephalomyelitis Disease-modifying treatments Connexins CP Molecular biology Children Post-partum Aquaporin-4 antibodies Cerebrospinal fluid BBB GSK-3β Myelin oligodendrocyte glycoprotein Aquaporin-4 antibody Central nervous system CSF Amino acid T follicular regulatory cells Immunosuppressant Autoantibodies Autoimmune diseases Astrocyte MOG antibodies